Larry Robbins' (Trades, Portfolio) Glenview Capital Management bought shares of the following stocks during the fourth quarter:
The guru boosted his position in Cigna Corp. (CI) by 177.24%, impacting the portfolio by 3.20%.
The company, which supplies medical and accident insurance products, has a market cap of $75.34 billion and an enterprise value of $76.26 billion.
GuruFocus gives the company a profitability and growth rating of 4 out of 10. While the return on equity of 19.06% is outperforming the sector, the return on assets of 4.14% is underperforming 57% of companies in the Global Health Care Plans industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.96 is below the industry median of 1.15.
The company's largest guru shareholder is Dodge & Cox with 3.47% of outstanding shares, followed by Barrow, Hanley, Mewhinney & Strauss with 1.17%, Robbins with 0.71% and Richard Pzena (Trades, Portfolio) with 1.36%.
The Shire Plc ADR (SHPG) position was expanded 55.63%, impacting the portfolio by 2.75%.
The company, which manufactures and develops medicines to care rare diseases, has a market cap of $55.04 billion and an enterprise value of $70.2 billion.
GuruFocus gives the company a profitability and growth rating of 9 out of 10. The return on equity of 13.33% and return on assets of 7.22% are outperforming 88% of companies in the Global Biotechnology industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.01 is below the industry median of 64.02.
John Paulson (Trades, Portfolio) is another notable guru shareholder of the company with 1% of outstanding shares, followed by Daniel Loeb (Trades, Portfolio)’s Third Point LLC with 0.56%, Lee Ainslie (Trades, Portfolio)’s Maverick Capital Ltd. with 0.28% and Jeremy Grantham (Trades, Portfolio)’s GMO LLC with 0.25%.
The guru raised his holding of DXC Technology Co. (DXC) by 92.55%. The portfolio was impacted by 0.85%.
The company, which supplies information technology and consulting services, has a market cap of $17.56 billion and an enterprise value of $22.98 billion.
GuruFocus gives the company a profitability and growth rating of 5 out of 10. The return on equity of 12.79% and return on assets of 5% are underperforming 59% of companies in the Global Information Technology Services industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 0.33 is below the industry median of 5.23.
Ainslie’s firm is another notable guru shareholder of the company with 2.1% of outstanding shares, followed by PRIMECAP Management (Trades, Portfolio) with 1.3%, Bill Nygren (Trades, Portfolio)’s Oakmark Fund with 0.93% and Pioneer Investments (Trades, Portfolio) with 0.32%.
The guru added 42.4% to his class A shares of Alphabet Inc. (GOOGL), impacting the portfolio by 1.34%.
The internet content products and portals provider has a market cap of $776.26 billion and an enterprise value of $671.13 billion.
GuruFocus gives the company a profitability and growth rating of 9 out of 10. The return on equity of 18.68% and return on assets of 14.36% are outperforming 56% of the companies in the Global Internet Content and Information industry. Its financial strength is rated 9 out of 10. The cash-debt ratio of 27.20 is above the industry median of 7.46.
The company's largest guru shareholder is PRIMECAP Management (Trades, Portfolio) with 0.32% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.19% and Frank Sands (Trades, Portfolio) with 0.17%.
The guru added 28.35% to his CVS Health Corp. (CVS) position. The trade had an impact of 1.19% on the portfolio.
The company, which offers pharmacy services, has a market cap of $89.92 billion and an enterprise value of $111.11 billion.
GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of 8.48% and return on assets of 2.65% are outperforming 61% of companies in the Global Health Care Plans industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 0.66 is below the industry median of 1.15.
Barrow, Hanley, Mewhinney & Strauss is the largest guru shareholder with 1.48% of outstanding shares, followed by Dodge & Cox with 1.24%, Vanguard Health Care Fund (Trades, Portfolio) with 0.91% and Bill Nygren (Trades, Portfolio)’s firm with 0.56%.
The guru added 13% to his HCA Healthcare Inc. (HCA) position. The trade had an impact of 0.68% on the portfolio.
The company, which operates general acute care hospitals, has a market cap of $49.65 billion and an enterprise value of $84 billion.
GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on assets of 10.02% is outperforming 71% of companies in the Global Medical Care industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.02 is below the industry median of 0.28.
With 2.12% of outstanding shares, Vanguard Health Care Fund (Trades, Portfolio) is the largest guru shareholder, followed by the Nygren’s firm with 1.14%, First Eagle Investment (Trades, Portfolio) with 0.67% and Pioneer Investments (Trades, Portfolio) with 0.37%.
The guru added 18.94% to the Hologic Inc. (HOLX) position. The trade had an impact of 0.63% on the portfolio.
The provider of diagnostics products has a market cap of $13.48 billion and an enterprise value of $16.32 billion.
GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of -16.24% and return on assets of -5.74% are outperforming 87% of companies in the Global Medical Instruments and Supplies industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.10 is below the industry median of 1.74.
Vanguard Health Care Fund (Trades, Portfolio) is another notable guru shareholder of the company with 1.69% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.69%, Jerome Dodson (Trades, Portfolio)’s Parnassus Fund with 0.28% and Steven Cohen (Trades, Portfolio)’s Point72 Asset Management with 0.19%.
Disclosure: I do not own any stocks mentioned.
